Experts Predict US Intravenous Immunoglobulin Market Trends Will Drive Growth Through 2035
The trajectory of the US intravenous immunoglobulin market is marked by distinctive trends that are shaping its future. With a forecasted growth from $2.7 billion in 2024 to approximately $4.05 billion by 2035, the market is expected to experience a compound annual growth rate (CAGR) of 3.75%. This uptick in growth is largely attributed to rising demand for effective immunotherapies to combat...
0 Commenti 0 condivisioni 11 Views 0 Anteprima